Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

Prognostic classification of endometrial cancer using a molecular approach based on a twelve-gene NGS panel.

López-Reig R, Fernández-Serra A, Romero I, Zorrero C, Illueca C, García-Casado Z, Poveda A, López-Guerrero JA.

Sci Rep. 2019 Dec 2;9(1):18093. doi: 10.1038/s41598-019-54624-x.

2.

Implementation of massive sequencing in the genetic diagnosis of hereditary cancer syndromes: diagnostic performance in the Hereditary Cancer Programme of the Valencia Community (FamCan-NGS).

Ramírez-Calvo M, García-Casado Z, Fernández-Serra A, de Juan I, Palanca S, Oltra S, Soto JL, Castillejo A, Barbera VM, Juan-Fita MJ, Segura Á, Chirivella I, Sánchez AB, Tena I, Chaparro C, Salas D, López-Guerrero JA.

Hered Cancer Clin Pract. 2019 Jan 18;17:3. doi: 10.1186/s13053-019-0104-x. eCollection 2019.

3.

Chemokine Expression Is Involved in the Vascular Neogenesis of Ewing Sarcoma: A Preliminary Analysis of the Early Stages of Angiogenesis in a Xenograft Model.

Giner F, López-Guerrero JA, Fernández-Serra A, Machado I, Mayordomo-Aranda E, Peydró-Olaya A, Llombart-Bosch A.

Pediatr Dev Pathol. 2019 Jan-Feb;22(1):30-39. doi: 10.1177/1093526618782497. Epub 2018 Jun 12.

PMID:
29895220
4.

Gene expression analyses determine two different subpopulations in KIT-negative GIST-like (KNGL) patients.

Moura DS, Ramos R, Fernandez-Serra A, Serrano T, Cruz J, Alvarez-Alegret R, Ortiz-Duran R, Vicioso L, Gomez-Dorronsoro ML, Garcia Del Muro X, Martinez-Trufero J, Rubio-Casadevall J, Sevilla I, Lainez N, Gutierrez A, Serrano C, Lopez-Alvarez M, Hindi N, Taron M, López-Guerrero JA, Martin-Broto J.

Oncotarget. 2018 Apr 3;9(25):17576-17588. doi: 10.18632/oncotarget.24799. eCollection 2018 Apr 3.

5.

PCA3 as a second-line biomarker in a prospective controlled randomized opportunistic prostate cancer screening programme.

Rubio-Briones J, Casanova J, Martínez F, Domínguez-Escrig JL, Fernández-Serra A, Dumont R, Ramírez-Backhaus M, Gómez-Ferrer A, Collado A, Rubio L, Molina A, Vanaclocha M, Sala D, Lopez-Guerrero JA.

Actas Urol Esp. 2017 Jun;41(5):300-308. doi: 10.1016/j.acuro.2016.10.008. Epub 2017 Mar 23. English, Spanish.

PMID:
28342633
6.

Expression profiles of angiogenesis in two high grade chondrosarcomas: A xenotransplant experience in nude mice.

Giner F, López-Guerrero JA, Machado I, García-Casado Z, Fernández-Serra A, Peydró-Olaya A, Llombart-Bosch A.

Histol Histopathol. 2017 Dec;32(12):1281-1291. doi: 10.14670/HH-11-880. Epub 2017 Feb 3.

PMID:
28155218
7.

Optimizing the clinical utility of PCA3 to diagnose prostate cancer in initial prostate biopsy.

Rubio-Briones J, Borque A, Esteban LM, Casanova J, Fernandez-Serra A, Rubio L, Casanova-Salas I, Sanz G, Domínguez-Escrig J, Collado A, Gómez-Ferrer A, Iborra I, Ramírez-Backhaus M, Martínez F, Calatrava A, Lopez-Guerrero JA.

BMC Cancer. 2015 Sep 11;15:633. doi: 10.1186/s12885-015-1623-0.

8.

[Update on the diagnosis of PCa in urine. The current role of urine markers].

Fernandez-Serra A, Casanova-Salas I, Rubio L, Calatrava A, García-Flores M, García-Casado Z, López-Guerrero JA, Rubio-Briones J.

Arch Esp Urol. 2015 Apr;68(3):240-9. Review. Spanish.

PMID:
25948797
9.

External validation of FXYD3 and KRT20 as predictive biomarkers for the presence of micrometastasis in muscle invasive bladder cancer lymph nodes.

Ramírez-Backhaus M, Fernández-Serra A, Rubio-Briones J, Cruz Garcia P, Calatrava A, Garcia Casado Z, Casanova Salas I, Rubio L, Solsona E, López-Guerrero JA.

Actas Urol Esp. 2015 Oct;39(8):473-81. doi: 10.1016/j.acuro.2015.02.002. Epub 2015 Apr 25. English, Spanish.

PMID:
25920992
10.

Clinico-pathological significance of the molecular alterations of the SPOP gene in prostate cancer.

García-Flores M, Casanova-Salas I, Rubio-Briones J, Calatrava A, Domínguez-Escrig J, Rubio L, Ramírez-Backhaus M, Fernández-Serra A, García-Casado Z, López-Guerrero JA.

Eur J Cancer. 2014 Nov;50(17):2994-3002. doi: 10.1016/j.ejca.2014.08.009. Epub 2014 Sep 6.

PMID:
25204806
11.

[New biomarkers to optimize the selection and follow up of patients with prostate cancer on active surveillance].

López-Guerrero JA, Casanova-Salas I, Fernández-Serra A, Rubio L, Calatrava A, García-Flores M, García-Casado Z, Rubio-Briones J.

Arch Esp Urol. 2014 Jun;67(5):462-72. Review. Spanish.

PMID:
24914846
12.

Identification of miR-187 and miR-182 as biomarkers of early diagnosis and prognosis in patients with prostate cancer treated with radical prostatectomy.

Casanova-Salas I, Rubio-Briones J, Calatrava A, Mancarella C, Masiá E, Casanova J, Fernández-Serra A, Rubio L, Ramírez-Backhaus M, Armiñán A, Domínguez-Escrig J, Martínez F, García-Casado Z, Scotlandi K, Vicent MJ, López-Guerrero JA.

J Urol. 2014 Jul;192(1):252-9. doi: 10.1016/j.juro.2014.01.107. Epub 2014 Feb 8.

PMID:
24518785
13.

Optimizing prostate cancer screening; prospective randomized controlled study of the role of PSA and PCA3 testing in a sequential manner in an opportunistic screening program.

Rubio-Briones J, Casanova J, Dumont R, Rubio L, Fernandez-Serra A, Casanova-Salas I, Domínguez-Escrig J, Ramírez-Backhaus M, Collado A, Gómez-Ferrer A, Iborra I, Monrós JL, Ricós JV, Solsona E, Salas D, Martínez F, Lopez-Guerrero JA.

Actas Urol Esp. 2014 May;38(4):217-23. doi: 10.1016/j.acuro.2013.09.007. Epub 2013 Oct 27. English, Spanish.

PMID:
24169211
14.

MRP1 overexpression determines poor prognosis in prospectively treated patients with localized high-risk soft tissue sarcoma of limbs and trunk wall: an ISG/GEIS study.

Martin-Broto J, Gutierrez AM, Ramos RF, Lopez-Guerrero JA, Ferrari S, Stacchiotti S, Picci P, Calabuig S, Collini P, Gambarotti M, Bague S, Dei Tos AP, Palassini E, Luna P, Cruz J, Cubedo R, Martinez-Trufero J, Poveda A, Casali PG, Fernandez-Serra A, Lopez-Pousa A, Gronchi A.

Mol Cancer Ther. 2014 Jan;13(1):249-59. doi: 10.1158/1535-7163.MCT-13-0406. Epub 2013 Oct 21.

15.

[Non-invasive diagnosis of prostate cancer: serum and urine markers].

Rubio-Briones J, Casanova-Casas I, Fernández-Serra A, Casanova Ramón-Borja J, Ramírez Backhaus M, Collado Sierra A, Domínguez-Escrig J, Gómez-Ferrer A, López-Guerrero JA.

Arch Esp Urol. 2013 Jun;66(5):440-52. Review. Spanish.

PMID:
23793762
16.

Molecular characterization and clinical impact of TMPRSS2-ERG rearrangement on prostate cancer: comparison between FISH and RT-PCR.

Fernández-Serra A, Rubio L, Calatrava A, Rubio-Briones J, Salgado R, Gil-Benso R, Espinet B, García-Casado Z, López-Guerrero JA.

Biomed Res Int. 2013;2013:465179. doi: 10.1155/2013/465179. Epub 2013 May 28.

17.

Fluorescence in situ hybridization for the differential diagnosis between Spitz naevus and spitzoid melanoma.

Requena C, Rubio L, Traves V, Sanmartín O, Nagore E, Llombart B, Serra C, Fernández-Serra A, Botella R, Guillén C.

Histopathology. 2012 Nov;61(5):899-909. doi: 10.1111/j.1365-2559.2012.04293.x. Epub 2012 Aug 8.

PMID:
22882594
18.

miRNAs as biomarkers in prostate cancer.

Casanova-Salas I, Rubio-Briones J, Fernández-Serra A, López-Guerrero JA.

Clin Transl Oncol. 2012 Nov;14(11):803-11. doi: 10.1007/s12094-012-0877-0. Epub 2012 Jul 24. Review.

PMID:
22855165
19.

A de novo complete BRCA1 gene deletion identified in a Spanish woman with early bilateral breast cancer.

Garcia-Casado Z, Romero I, Fernandez-Serra A, Rubio L, Llopis F, Garcia A, Llombart P, Lopez-Guerrero JA.

BMC Med Genet. 2011 Oct 11;12:134. doi: 10.1186/1471-2350-12-134.

20.

[Outcomes of expanded use of PCA3 testing in a Spanish population with clinical suspicion of prostate cancer].

Rubio-Briones J, Fernández-Serra A, Ramírez M, Rubio L, Collado A, Casanova J, Gómez-Ferrer A, Ricós JV, Monrós JL, Dumont R, Ortiz B, Iborra I, García-Casado Z, Solsona E, López-Guerrero JA.

Actas Urol Esp. 2011 Nov-Dec;35(10):589-96. doi: 10.1016/j.acuro.2011.04.001. Epub 2011 Jun 22. Spanish.

PMID:
21700365
21.

[Prostate cancer: the revolution of the fusion genes].

Fernández-Serra A, Rubio-Briones J, García-Casado Z, Solsona E, López-Guerrero JA.

Actas Urol Esp. 2011 Jul-Aug;35(7):420-8. doi: 10.1016/j.acuro.2010.11.019. Epub 2011 May 23. Review. Spanish.

PMID:
21601955
22.

Dermatofibrosarcoma protuberans: a clinicopathological, immunohistochemical, genetic (COL1A1-PDGFB), and therapeutic study of low-grade versus high-grade (fibrosarcomatous) tumors.

Llombart B, Monteagudo C, Sanmartín O, López-Guerrero JA, Serra-Guillén C, Poveda A, Jorda E, Fernandez-Serra A, Pellín A, Guillén C, Llombart-Bosch A.

J Am Acad Dermatol. 2011 Sep;65(3):564-575. doi: 10.1016/j.jaad.2010.06.020. Epub 2011 May 12.

PMID:
21570152
23.

Molecular diagnosis of dermatofibrosarcoma protuberans: a comparison between reverse transcriptase-polymerase chain reaction and fluorescence in situ hybridization methodologies.

Salgado R, Llombart B, M Pujol R, Fernández-Serra A, Sanmartín O, Toll A, Rubio L, Segura S, Barranco C, Serra-Guillén C, Yébenes M, Salido M, Traves V, Monteagudo C, Sáez E, Hernández T, de Álava E, Llombart-Bosch A, Solé F, Guillén C, Espinet B, López-Guerrero JA.

Genes Chromosomes Cancer. 2011 Jul;50(7):510-7. doi: 10.1002/gcc.20874. Epub 2011 Apr 11.

PMID:
21484928
24.

[Immunohistochemical expression of microvascular density and carbonic anhidrase IX in renal carcinoma. Relation to histological type and tumoral progression].

Rubio-Briones J, Calatrava A, Fernández-Serra A, Ramos Ruiz R, Iborra I, García-Casado Z, Rubio L, Trassierra M, Collado A, Casanova J, Gómez-Ferrer A, Solsona E, López-Guerrero JA.

Actas Urol Esp. 2011 Feb;35(2):80-6. doi: 10.1016/j.acuro.2010.10.003. Epub 2011 Jan 21. Spanish.

PMID:
21256634
25.

Clinical implications of TMPRSS2-ERG gene fusion expression in patients with prostate cancer treated with radical prostatectomy.

Rubio-Briones J, Fernández-Serra A, Calatrava A, García-Casado Z, Rubio L, Bonillo MA, Iborra I, Solsona E, López-Guerrero JA.

J Urol. 2010 May;183(5):2054-61. doi: 10.1016/j.juro.2009.12.096. Epub 2010 Mar 19.

PMID:
20303538
26.

A polymorphism at the 3'-UTR region of the aromatase gene defines a subgroup of postmenopausal breast cancer patients with poor response to neoadjuvant letrozole.

Garcia-Casado Z, Guerrero-Zotano A, Llombart-Cussac A, Calatrava A, Fernandez-Serra A, Ruiz-Simon A, Gavila J, Climent MA, Almenar S, Cervera-Deval J, Campos J, Albaladejo CV, Llombart-Bosch A, Guillem V, Lopez-Guerrero JA.

BMC Cancer. 2010 Feb 9;10:36. doi: 10.1186/1471-2407-10-36.

27.

A germline mutation of p14/ARF in a melanoma kindred.

Garcia-Casado Z, Nagore E, Fernandez-Serra A, Botella-Estrada R, Lopez-Guerrero JA.

Melanoma Res. 2009 Oct;19(5):335-7. doi: 10.1097/CMR.0b013e32832dd2d4. No abstract available.

PMID:
19741424
28.

Genetic counseling in renal masses.

López-Guerrero JA, García-Casado Z, Fernández-Serra A, Rubio-Briones J.

Adv Urol. 2008:720840. doi: 10.1155/2008/720840. Epub 2008 Nov 9.

Supplemental Content

Loading ...
Support Center